BioCentury | May 28, 2019
Distillery Therapeutics
TSPO agonist to treat Parkinson's disease
...in cells expressing TSPO compared with TSPO-knockout cells. In a mouse model of PD, the TSPO...
...has TRO40303, a TSPO ligand, in Phase II testing for ischemia/reperfusion injury. TARGET/MARKER/PATHWAY: Peripheral benzodiazepine receptor (TSPO; PBR...
...German Center for Neurodegenerative Diseases, Bonn, Germany email: anja.schneider@dzne.de Chris Lieu German Center for Neurodegenerative Diseases Peripheral benzodiazepine receptor (TSPO) (PBR) Parkinson's...
...has TRO40303, a TSPO ligand, in Phase II testing for ischemia/reperfusion injury. TARGET/MARKER/PATHWAY: Peripheral benzodiazepine receptor (TSPO; PBR...
...German Center for Neurodegenerative Diseases, Bonn, Germany email: anja.schneider@dzne.de Chris Lieu German Center for Neurodegenerative Diseases Peripheral benzodiazepine receptor (TSPO) (PBR) Parkinson's...